5,8-Dihydro-1,7-Naphthyridine Derivatives As Glp-1 Agonists For The Treatment Of Diabetes - EP4496797
The patent EP4496797 was granted to Gasherbrum BIO on Jan 29, 2025. The application was originally filed on Mar 20, 2023 under application number EP23718162A. The patent is currently recorded with a legal status of "Request For Examination Was Made".
EP4496797
- Application Number
- EP23718162A
- Filing Date
- Mar 20, 2023
- Status
- Request For Examination Was Made
- Dec 26, 2024
- Publication Date
- Jan 29, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents